Articles

Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia

Immunology, Division of Molecular & Clinical Cancer Sciences, University of Manchester, UK
Paediatric Oncology, Division of Molecular & Clinical Cancer Sciences, University of Manchester, UK;Tata Translational Cancer Research Center, Tata Medical Center, Kolkata, India
Division of Oncology & Children’s Research Center, University Children’s Hospital, University of Zurich, Switzerland
Pfizer Inc. Pearl River, NY10965-1299, USA
Paediatric Oncology, Division of Molecular & Clinical Cancer Sciences, University of Manchester, UK
Paediatric Oncology, Division of Molecular & Clinical Cancer Sciences, University of Manchester, UK;Tata Translational Cancer Research Center, Tata Medical Center, Kolkata, India
Immunology, Division of Molecular & Clinical Cancer Sciences, University of Manchester, UK
Vol. 102 No. 6 (2017): June, 2017 https://doi.org/10.3324/haematol.2016.158485